Q BioMed Inc. Discusses Revenue Potential of International Commercialization and Expansion of Strontium89 with The Stock Day Podcast
Oct 14, 2020, 12:16 PM
The Stock Day Podcast welcomed Q BioMed Inc. (QBIO)(“the Company”), a biotech acceleration and commercial stage company. CEO of the Company, Denis Corin, joined Stock Day host Everett Jolly.